Fluorogenic Kallikrein Substrate

CAT:
952-B2012780
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Fluorogenic Kallikrein Substrate - image 1

Fluorogenic Kallikrein Substrate

  • Description:

    Fluorogenic Kallikrein Substrate_x000D_ Catalog number: B2012780_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 1 mg_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Lyophilized Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: -20°C_x000D_ Keywords: Kallikrein Substrate, Fluorogenic - Calbiochem_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Kato H, Adachi N, Iwanaga S, Abe K, Takada K, Kimura T, Sakakibara S. A new fluorogenic substrate method for the estimation of kallikrein in urine J Biochem. 1980 Apr;87(4):1127-32._x000D_ 2: Biltoft D, Sidelmann JJ, Olsen LF, Palarasah Y, Gram J. Calibrated kallikrein generation in human plasma Clin Biochem. 2016 Oct;49(15):1188-1194._x000D_ 3: Ramani VC, Haun RS. The extracellular matrix protein fibronectin is a substrate for kallikrein 7 Biochem Biophys Res Commun. 2008 May 16;369(4):1169-73._x000D_ 4: Richards GP, Zintz C, Chao J, Chao L. Purification and characterization of salivary kallikrein from an insectivore (Scalopus aquaticus): substrate specificities, immunoreactivity, and kinetic analyses Arch Biochem Biophys. 1996 May 1;329(1):104-12._x000D_ 5: Borgoño CA, Gavigan JA, Alves J, Bowles B, Harris JL, Sotiropoulou G, Diamandis EP. Defining the extended substrate specificity of kallikrein 1-related peptidases Biol Chem. 2007 Nov;388(11):1215-25._x000D_ 6: Gosalia DN, Salisbury CM, Ellman JA, Diamond SL. High throughput substrate specificity profiling of serine and cysteine proteases using solution-phase fluorogenic peptide microarrays Mol Cell Proteomics. 2005 May;4(5):626-36._x000D_ 7: Gruba N, Rachubik P, Piwkowska A, Lesner A. Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer Biomarkers. 2021 Dec;26(8):770-779._x000D_ 8: Elmoujahed A, Gutman N, Brillard M, Gauthier F. Substrate specificity of two kallikrein family gene products isolated from the rat submaxillary gland FEBS Lett. 1990 Jun 4;265(1-2):137-40._x000D_ 9: Chagas JR, Hirata IY, Juliano MA, Xiong W, Wang C, Chao J, Juliano L, Prado ES. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing Biochemistry. 1992 Jun 2;31(21):4969-74._x000D_ 10: Duckworth EJ, Murugesan N, Li L, Rushbrooke LJ, Lee DK, De Donatis GM, Maetzel A, Yea CM, Hampton SL, Feener EP. Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema Clin Exp Allergy. 2022 Sep;52(9):1059-1070. _x000D_ _x000D_ Products Related to Fluorogenic Kallikrein Substrate can be found at Substrates
  • Short Description:

    Catalog Number: B2012780 (1 mg)
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height:

    0.5
  • Height :

    0.5